Recommended Stock Newsletters
#1. Jason Bond Picks #2. Nova Stocks
-
-
Recent Market Articles
- OCCUPY DC BEING EVICTED NOW
- OCCUPY DC BEING EVICTED NOW
- OTTR, SSW Dividend Stocks Update
- Today in NYC: Occupy the Bronx Says "Stop Police Brutality!" Plus, Day of Action to Support Iranian Democracy
- OCCUPY DC BEING EVICTED NOW
- In Spite of Elections and "Camping Bans," Revolutionary Wave Grows
- HSM, HTR, HNW, PHT, HHY Dividend Stocks Update
Recent Events
Stocks to Watch
Analyst Updates
Dividend Stocks
Stock Scans
- GPS, BK, GILD, SOA, UAL are Stocks Trending Up
- ZNGA, MSFT, QQQ, QCOM, DELL Hit New 52-Week Highs
- CX, ZNGA, EA, GMCR, GPS Had Unusual Volume
- GPS, BK, GILD, SOA, UAL are Stocks Trending Up
- ZNGA, MSFT, QQQ, QCOM, DELL Hit New 52-Week Highs
- CX, ZNGA, EA, GMCR, GPS Had Unusual Volume
- DELL, USB, CMCSA, BK, GILD are Stocks Trending Up
- STX, MSFT, QQQ, CMCSA, WMT Hit New 52-Week Highs
- STX, BRCM, GGB, RSH, FTNT Had Unusual Volume
- HOLX, UAL, GILD, CA, ARR are Stocks Trending Up
Earnings
Tag Archives: PFE
KCAP, FTT, PFE, NX Dividend Stocks Update
Kohlberg Capital Corp. (NASDAQ:KCAP) has declared a new dividend of $0.18 . The dividend record date is set for Friday, December 23, 2011 with a pay date being announced as Friday, January 27, 2012 and the ex-date is Wednesday, December … Continue reading
Pfizer Raises Dividend; Announces New Share Repurchase Program (PFE)
Pfizer Inc. (NYSE: PFE), the New York City-based global pharmaceutical company, today announced that its Board of Directors raised the quarterly dividend by 10%.
Ranbaxy Laboratories Downgraded by UBS
Ranbaxy Laboratories have been downgraded by UBS, banking and financial service group, from buy to neutral, a day after the company began selling generic versions of Pfizer’s (NYSE:PFE) Lipitor.
Teva Plans to Introduce Generic Version of Lipitor in May (TEVA, PFE)
Teva Pharmaceuticals Industries Limited (ADR) (NASDAQ: TEVA), the Israel-based global pharmaceutical and drug company, said that regulators in the U.S. gave a tentative approval to the company’s generic version of Pfizer Inc.’s (NYSE: PFE) blockbuster cholesterol drug Lipitor. Teva said … Continue reading
Futures Point to a Flat Opening
Futures are pointing to a flat opening for the U.S. equity market as investors take a breather after Wednesday’s huge rally that saw all three major indexes finish more than 4% higher. Wednesday’s rally was sparked by the announcement from … Continue reading
Pfizer’s Patent on Blockbuster Cholesterol Drug Expires (PFE)
Pfizer Inc.’s (NYSE: PFE) patent on Lipitor, a cholesterol-lowering drug, expired today, clearing the way for generic version of the blockbuster drug. Lipitor, which is best-selling drug of al-time, is the most popular medication in the U.S.
Futures Point to a Lower Start
Stock index futures are pointing to a lower start for the U.S. equity market as reports that the U.S. congressional supercommittee assigned to come up with a plan to cut U.S. deficit failed to reach an agreement.
